The Autoimmune Risk Variant PTPN22 C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive Repertoire.
Genita MetzlerXuezhi DaiChristopher D ThouvenelSocheath KhimTania HabibJane H BucknerDavid J RawlingsPublished in: Journal of immunology (Baltimore, Md. : 1950) (2017)
A common genetic variant in the gene encoding the protein tyrosine phosphatase nonreceptor type 22 (PTPN22 C1858T) has been linked to a wide range of autoimmune disorders. Although a B cell-intrinsic role in promoting disease has been reported, the mechanism(s) through which this variant functions to alter the preimmune B cell repertoire remains unknown. Using a series of polyclonal and transgenic self-reactive models harboring the analogous mutation in murine Ptpn22, we show evidence for enhanced BCR, B cell-activating factor receptor, and CD40 coreceptor programs, leading to broadly enhanced positive selection of B cells at two discrete checkpoints in the bone marrow and spleen. We further identified a bias for selection of B cells into the follicular mature versus marginal zone B cell compartment. Using a biomarker to track a self-reactive H chain in peripheral blood, we found evidence of similarly enhanced positive selection in human carriers of the PTPN22 C1858T variant. Our combined data support a model whereby the risk variant augments the BCR and coreceptor programs throughout B cell development, promoting enrichment of self-reactive specificities into the follicular mature compartment and thereby likely increasing the risk for seeding of autoimmune B cell responses.
Keyphrases
- bone marrow
- peripheral blood
- multiple sclerosis
- acute lymphoblastic leukemia
- public health
- genome wide
- mesenchymal stem cells
- tyrosine kinase
- copy number
- gene expression
- dna methylation
- deep learning
- drug induced
- small molecule
- induced pluripotent stem cells
- data analysis
- protein kinase
- genome wide identification
- high throughput sequencing